Skip to main content

Avalo Therapeutics Inc (NQ: AVTX )

9.650 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
November 30, 2004
Form 8-K
Source: SEC/Edgar
October 20, 2004
Form 8-K
Source: SEC/Edgar
September 09, 2004
Form 10QSB
Source: SEC/Edgar
August 15, 2004
Form 10QSB/A
Source: SEC/Edgar
May 18, 2004
Form 10QSB
Source: SEC/Edgar
May 12, 2004
Form 8-K
Source: SEC/Edgar
March 04, 2004
Form 10QSB
Source: SEC/Edgar
February 16, 2004
Form 10KSB
Source: SEC/Edgar
January 13, 2004
Form NT 10-K
Source: SEC/Edgar
December 28, 2003
Form 10QSB
Source: SEC/Edgar
August 06, 2003
Form 10QSB
Source: SEC/Edgar
May 13, 2003
Form 10QSB/A
Source: SEC/Edgar
March 02, 2003
Form 10QSB/A
Source: SEC/Edgar
February 24, 2003
Form 10QSB
Source: SEC/Edgar
February 13, 2003
Form 10KSB
Source: SEC/Edgar
January 06, 2003
Form NT 10-K
Source: SEC/Edgar
December 29, 2002
Form 10QSB
Source: SEC/Edgar
August 13, 2002
Form 10QSB
Source: SEC/Edgar
May 14, 2002
Form 10QSB/A
Source: SEC/Edgar
April 23, 2002
Form 8-K/A
Source: SEC/Edgar
April 23, 2002
Form 10KSB/A
Source: SEC/Edgar
April 22, 2002
Form 10QSB
Source: SEC/Edgar
February 14, 2002
Form 10KSB
Source: SEC/Edgar
December 30, 2001
Form S-8
Source: SEC/Edgar
December 30, 2001
Form 8-K
Source: SEC/Edgar
October 01, 2001
Form 10QSB
Source: SEC/Edgar
August 13, 2001
Form 10KSB/A
Source: SEC/Edgar
June 17, 2001
Form 10QSB/A
Source: SEC/Edgar
June 17, 2001
Form 10KSB/A
Source: SEC/Edgar
June 17, 2001
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.